Scholars@Duke

Factor XI inhibition for ACS patients: premises and prospects.

Publication ,  Journal Article
Lopes, RD; Fanaroff, AC
Published in: EuroIntervention
July 21, 2025
Published version (DOI) Link to item

Duke Scholars

Renato Delascio Lopes
Author Renato Delascio Lopes Medicine, Cardiology

Published In

EuroIntervention

DOI

10.4244/EIJ-D-24-00943

EISSN

1969-6213

Publication Date

July 21, 2025

Volume

21

Issue

14

Start / End Page

e776 / e777

Location

France

Related Subject Headings

  • 3201 Cardiovascular medicine and haematology
  • 0104 Statistics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lopes, R. D., & Fanaroff, A. C. (2025). Factor XI inhibition for ACS patients: premises and prospects. EuroIntervention, 21(14), e776–e777. https://doi.org/10.4244/EIJ-D-24-00943
Lopes, Renato D., and Alexander C. Fanaroff. “Factor XI inhibition for ACS patients: premises and prospects.” EuroIntervention 21, no. 14 (July 21, 2025): e776–77. https://doi.org/10.4244/EIJ-D-24-00943.
Lopes RD, Fanaroff AC. Factor XI inhibition for ACS patients: premises and prospects. EuroIntervention. 2025 Jul 21;21(14):e776–7.
Lopes, Renato D., and Alexander C. Fanaroff. “Factor XI inhibition for ACS patients: premises and prospects.” EuroIntervention, vol. 21, no. 14, July 2025, pp. e776–77. Pubmed, doi:10.4244/EIJ-D-24-00943.
Lopes RD, Fanaroff AC. Factor XI inhibition for ACS patients: premises and prospects. EuroIntervention. 2025 Jul 21;21(14):e776–e777.

Published In

EuroIntervention

DOI

10.4244/EIJ-D-24-00943

EISSN

1969-6213

Publication Date

July 21, 2025

Volume

21

Issue

14

Start / End Page

e776 / e777

Location

France

Related Subject Headings

  • 3201 Cardiovascular medicine and haematology
  • 0104 Statistics